drugset

drugset / Trial / NCT00471419

Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye

NCT00471419 ↗

Phase 3 Completed 750 enrolled Alcon Research

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.

Timeline

Start: 2006-07
Primary completion: 2007-08
Completion: 2007-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rimexolone	Other / unclassified	—	—

Indications